Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 521 entries
View as:

Solifenacin Succinate Versus Tolterodine 4mg Once Daily

Phase: N/A Priority: Normal
NCT ID: NCT00802373 Org: User:
Start: 07/31/03 End: 10/31/04 Due: 10/31/05

Oral Multiple-dose Study in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01924520 Org: User:
Start: 11/30/10 End: 05/31/11 Due: 05/31/12

LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00328588 Org: User:
Start: 12/31/06 End: 03/31/07 Due: 03/31/08

Drug to Drug Interaction Study With ASP1941 and Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01302145 Org: User:
Start: 02/25/09 End: 12/09/09 Due: 12/09/10

A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00666302 Org: User:
Start: 10/31/02 End: 11/30/03 Due: 11/30/04

A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01478607 Org: User:
Start: 11/30/11 End: 02/28/14 Due: 02/28/15

Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01870908 Org: User:
Start: 08/31/12 End: 03/31/15 Due: 03/31/16

A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00750620 Org: User:
Start: 09/30/08 End: 09/30/09 Due: 09/30/10

Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00560326 Org: User:
Start: 06/30/03 End: 12/31/06 Due: 12/31/07

CP-461 for the Treatment of Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00042055 Org: User:
Start: 07/31/02 End: 09/30/03 Due: 09/30/04

Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00851318 Org: User:
Start: 03/31/09 End: 06/30/13 Due: 06/30/14

ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-

Phase: N/A Priority: Normal
NCT ID: NCT01964196 Org: User:
Start: 09/17/13 End: 12/01/15 Due: 12/01/16

A Study to Investigate the Plasma Concentration of YM150 After Repeated Administration to Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01514825 Org: User:
Start: 11/30/06 End: 02/28/07 Due: 02/28/08

Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch

Phase: N/A Priority: Normal
NCT ID: NCT01416116 Org: User:
Start: 07/06/11 End: 04/25/12 Due: 04/25/13

Study of CP-461 in Patients With Advanced Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00036036 Org: User:
Start: 07/31/01 End: 07/31/03 Due: 07/31/04

A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)

Phase: N/A Priority: Normal
NCT ID: NCT00189813 Org: User:
Start: 03/31/05 End: 12/31/05 Due: 12/31/06

Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement

Phase: N/A Priority: Normal
NCT ID: NCT00408239 Org: User:
Start: 12/31/06 End: 03/31/09 Due: 03/31/10

Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00448214 Org: User:
Start: 03/31/07 End: 10/31/08 Due: 10/31/09

YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00050297 Org: User:
Start: - End: 02/29/04 Due: 02/28/05

A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Methotrexate in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01754805 Org: User:
Start: 01/22/10 End: 03/25/10 Due: 03/25/11

A Study to Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00282230 Org: User:
Start: 11/30/03 End: 10/31/05 Due: 10/31/06

To Evaluate if Multiple Doses of Ketoconazole Change the Blood Concentration of YM150 (Darexaban)

Phase: N/A Priority: Normal
NCT ID: NCT01405989 Org: User:
Start: 01/31/10 End: 03/31/10 Due: 03/31/11

A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01096862 Org: User:
Start: 03/23/10 End: 07/27/11 Due: 07/27/12

A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients

Phase: N/A Priority: Normal
NCT ID: NCT03053427 Org: User:
Start: 03/30/17 End: 06/25/18 Due: 06/25/19

Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00463541 Org: User:
Start: 06/30/04 End: 04/30/05 Due: 04/30/06